|
| 派林生物(000403)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-02-04 | 4033.37 | 5.52% | 72504.79 | 602.70 | 68471.42 | 93.66% | 定向增发机构配售股份 | | 2024-02-27 | 4784.90 | 6.53% | 68766.73 | 4507.70 | 63981.83 | 87.32% | 定向增发机构配售股份 | | 2024-02-07 | 8.97 | 0.01% | 63962.41 | 9312.02 | 63953.44 | 87.28% | 股权分置限售股份 | | 2023-07-13 | 117.13 | 0.16% | 63613.03 | 9651.54 | 63646.63 | 86.87% | 股权激励限售股份 | | 2023-02-13 | 3651.06 | 4.98% | 63943.02 | 9300.31 | 63943.02 | 87.30% | 定向增发机构配售股份 | | 2022-07-15 | 94.17 | 0.13% | 60317.49 | 12979.54 | 60317.49 | 82.29% | 股权激励限售股份 | | 2022-02-07 | 17630.35 | 24.05% | 60276.06 | 13015.86 | 60276.06 | 82.24% | 定向增发机构配售股份 | | 2021-08-23 | 4800.48 | 6.55% | 53651.82 | 19625.94 | 73277.76 | 100.00% | 增发A股法人配售上市 | | 2021-06-15 | 88.88 | 0.12% | 48805.87 | 24439.84 | 73245.71 | 100.00% | 股权激励限售流通 | | 2020-12-11 | 5.60 | 0.01% | 48716.99 | 526.48 | 49243.47 | 100.00% | 股权分置限售流通 | | 2019-03-15 | 0.24 | 0.00% | 27140.80 | 116.96 | 27257.76 | 100.00% | 股权分置限售流通 | | 2019-01-22 | 609.00 | 2.23% | 27140.56 | 117.20 | 27257.76 | 100.00% | 股权分置限售流通 | | 2018-03-06 | 260.13 | 0.95% | 26531.56 | 726.20 | 27257.76 | 100.00% | 股权分置限售流通 | | 2017-11-14 | 6162.11 | 22.61% | 26271.43 | 986.33 | 27257.76 | 100.00% | 股权分置限售流通 | | 2017-07-07 | 73.59 | 0.27% | 20109.32 | 7148.44 | 27257.76 | 100.00% | 股权分置限售流通 | | 2017-04-14 | 1216.52 | 4.46% | 20035.73 | 7222.03 | 27257.76 | 100.00% | 股权分置限售流通 | | 2016-09-27 | 86.00 | 0.32% | 18819.21 | 8438.55 | 27257.76 | 100.00% | 股权分置限售流通 | | 2016-02-01 | 554.97 | 2.04% | 18733.21 | 8524.55 | 27257.76 | 100.00% | 股权分置限售流通 | | 2015-04-30 | 24.00 | 0.09% | 18178.25 | 9079.51 | 27257.76 | 100.00% | 股权分置限售流通 | | 2014-08-06 | 274.00 | 1.01% | 18154.25 | 9103.51 | 27257.76 | 100.00% | 股权分置限售流通 | | 2014-04-03 | 1554.14 | 5.70% | 17880.25 | 9377.51 | 27257.76 | 100.00% | 股权分置限售流通 | | 2014-02-10 | 87.68 | 0.32% | 16326.11 | 10931.65 | 27257.76 | 100.00% | 股权分置限售流通 |
|